Current guidelines for high-density lipoprotein cholesterol in therapy and future directions

Many studies have suggested that a significant risk factor for atherosclerotic cardiovascular disease (ASCVD) is low high-density lipoprotein cholesterol (HDL-C). Therefore, increasing HDL-C with therapeutic agents has been considered an attractive strategy. In the prestatin era, fibrates and niacin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Subedi, Bishnu H, Joshi, Parag H, Jones, Steven R, Martin, Seth S, Blaha, Michael J, Michos, Erin D
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986285/
https://ncbi.nlm.nih.gov/pubmed/24748800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S45648
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares